Lindner O, Burchert W, Bengel F M, Zimmermann R, Vom Dahl J, Schäfer W, Schober O, Schäfers M
Institut für Radiologie, Nuklearmedizin und Molekulare Bildgebung, Herz- und Diabeteszentrum NRW, Georgstr. 11, 32545 Bad Oeynhausen, Germany.
Nuklearmedizin. 2010;49(2):65-72. doi: 10.3413/nukmed-0282. Epub 2010 Mar 1.
The working group Cardiovascular Nuclear Medicine of the German Society of Nuclear Medicine in cooperation with the working group Nuclear Cardiology of the German Cardiac Society herewith present the results of the 4th survey on myocardial perfusion scintigraphy (MPS) of the year 2008.
310 questionnaires (191 private practices (PP), 93 hospitals (HO), 31 university hospitals (UH)) were evaluated.
MPS of 98947 patients were reported. 15% of them were younger than 50 y, 57% between 50 and 70 y and 28% older than 70 y. 88% [2007: 83%] of all were studied with Tc-99m perfusion tracers. The patient radiation exposure of a stress and rest protocol considering German standard recommended doses was 8.5 mSv, of a stress-only protocol 1.9 mSv. 77% [2007: 76%] of the MPS were performed in PP, 15% [2007: 15%] in HO and 8% [2007: 9%] in UH. From 2005 to 2008 there was a mild increase in the MPS numbers by 1.2% (PP +7.1%, HO -5.5%, UH -31.4%). The type of stress was pharmacological in 30% [2007: 27%]; 68% adenosine (of these 22% with exercise), 29% dipyridamole (of these 64% with exercise), and <1% dobutamine. Gated SPECT was performed in 46% [2007: 47%] of all rest and in 42% [2007: 44%] of all stress MPS. 62% [2007: 61%] of all institutions did not use perfusion scores.
The MPS numbers from 2005 to 2008 in Germany can be regarded as stable. However, there are considerable shifts from HO and UH to PP. The well known potential of MPS considering risk stratification and functional analysis has not been tapped so far. Both gated SPECT and a quantitative perfusion analysis should be performed routinely in every patient.
德国核医学协会心血管核医学工作组与德国心脏病学会核心脏病学工作组特此公布2008年第四次心肌灌注闪烁显像（MPS）调查结果。
对310份问卷（191份私人诊所问卷、93份医院问卷、31份大学医院问卷）进行了评估。
共报告了98947例患者的MPS检查情况。其中15%年龄小于50岁，57%年龄在50至70岁之间，28%年龄大于70岁。所有检查中88%[2007年：83%]使用锝-99m灌注示踪剂。按照德国标准推荐剂量，负荷及静息检查方案下患者接受的辐射剂量为8.5毫希沃特，仅负荷检查方案下为1.9毫希沃特。77%[2007年：76%]的MPS检查在私人诊所进行，15%[2007年：15%]在医院进行，8%[2007年：9%]在大学医院进行。从2005年到2008年，MPS检查数量略有增加，增幅为1.2%（私人诊所增加7.1%，医院减少5.5%，大学医院减少31.4%）。30%[2007年：27%]的负荷检查采用药物负荷；68%使用腺苷（其中22%联合运动），29%使用双嘧达莫（其中64%联合运动），多巴酚丁胺使用比例小于1%。所有静息MPS检查中46%[2007年：47%]及所有负荷MPS检查中42%[2007年：44%]进行了门控单光子发射计算机断层显像（gated SPECT）。62%[2007年：61%]机构未使用灌注评分。
2005年至2008年德国的MPS检查数量可视为稳定。然而，医院和大学医院的检查数量大幅转向私人诊所。MPS在风险分层和功能分析方面的显著潜力尚未得到充分利用。应常规对每位患者进行门控SPECT和定量灌注分析。
